Cargando…
Effects of novel Fufang Biejia Ruangan Tablets with sheep placenta as substitute for Hominis Placenta on CCl(4)-induced liver fibrosis
OBJECTIVE: Fufang Biejia Ruangan Tablet (FBRT) is widely used for the treatment of liver fibrosis. However, Hominis Placenta (HP), as an important adjuvant of FBRT, has been restricted for medicinal using due to the limited availability, ethical controversy and safety issues. The present study aimed...
Autores principales: | Shen, Baode, Deng, Li, Liu, Yuan, Li, Ruisheng, Shen, Chengying, Liu, Xiao, Li, Yinchao, Yuan, Hailong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476806/ https://www.ncbi.nlm.nih.gov/pubmed/36120135 http://dx.doi.org/10.1016/j.chmed.2021.09.013 |
Ejemplares similares
-
Efficacy and safety of Fufang Biejia Ruangan Tablets as an adjuvant treatment for chronic hepatitis B liver fibrosis: A systematic review and meta-analysis
por: Meng, Xiangbo, et al.
Publicado: (2022) -
Effect of Fufang Biejia Ruangan Tablet on lowering biochemical and virological parameters of hepatic fibrosis in patients with chronic hepatitis B: Protocol for a systematic review and meta-analysis of randomized controlled trials and cohort studies
por: Huang, Chaoyuan, et al.
Publicado: (2019) -
Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients
por: Jiang, Ting-Ting, et al.
Publicado: (2021) -
Effective authentication of Placenta Hominis
por: Lo, Yat-Tung, et al.
Publicado: (2018) -
Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial
por: Qu, Jianhui, et al.
Publicado: (2014)